BEAM Insider Trading Activity and SEC Form 4 Filings
BEAM insider trading summary
Over the past 12 months, insiders at Beam Therapeutics Inc. (BEAM) reported 27 sales worth $19.0M by 7 insiders and no open-market purchases on SEC Form 4. Net insider selling was $19.0M.
Latest BEAM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 16, 2026 | John M. Evans | CEO | Sell | $600K (25,000 @ $23.98) |
| Oct 15, 2026 | John M. Evans | CEO | Sell | $589K (25,000 @ $23.57) |
| Oct 1, 2026 | Bethany J Cavanagh | SVP, Finance and Treasurer | Sell | $5K (187 @ $24.41) |
| Jun 30, 2026 | John M. Evans | CEO | Sell | $66K (1,900 @ $34.84) |
| Jun 30, 2026 | John M. Evans | CEO | Sell | $791K (23,100 @ $34.26) |
| Jun 29, 2026 | John M. Evans | CEO | Sell | $472K (13,421 @ $35.13) |
| Jun 29, 2026 | John M. Evans | CEO | Sell | $416K (11,579 @ $35.91) |
| Jun 26, 2026 | FMR LLC | Insider | Sell | $8.9M (251,488 @ $35.26) |
| Jun 25, 2026 | FMR LLC | Insider | Sell | $1.2M (33,372 @ $35.12) |
| Apr 1, 2026 | John M. Evans | CEO | Sell | $739K (30,078 @ $24.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.